Prosecution Insights
Last updated: October 04, 2026

Fishburne May LLC

Technology area: Medical Devices & Mechanical Engineering

2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Fishburne May LLC is currently managing 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. Both of these actions are assigned to 1 distinct examiner, creating a high level of centralization for the company's current prosecution. Furthermore, the entire pending workload is situated within 1 distinct art unit.

ROZANSKI, GRACE NMN is the busiest examiner for this portfolio, overseeing 2 pending office actions. This examiner is responsible for every active challenge the company currently faces at the patent office. For the applicant, this means that the prosecution strategy is focused on the preferences and precedents of this examiner and art unit. Such a concentrated profile simplifies communication but increases the impact of any single examiner's specific interpretation of the prior art. With 2 actions in 1 art unit, the company must ensure its arguments are aligned with the technical standards of that unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Double-patenting + other1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
2
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ROZANSKI, GRACE NMN 2 60.5% +20.7%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17171196 Bodily Fluid Indicator Devices and Methods ROZANSKI, GRACE NMN 54d
18240083 BODILY FLUID INDICATOR DEVICES AND METHODS ROZANSKI, GRACE NMN 82d

Top Art Units

Art UnitApps
3791 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18240083 BODILY FLUID INDICATOR DEVICES AND METHODS ROZANSKI, GRACE NMN 3791 §102§103DP Final Rejection 82d Pending Aug 30, 2023
17171196 Bodily Fluid Indicator Devices and Methods ROZANSKI, GRACE NMN 3791 §103Other Non-Final OA 54d Pending Feb 09, 2021

Managing Fishburne May LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month